Properties (57)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
medication
|
| gptkbp:activeDuring |
gptkb:teduglutide
|
| gptkbp:administrativeDivision |
once daily
|
| gptkbp:availability |
specialty pharmacies
|
| gptkbp:clinicalTrials |
yes
Phase 3 ongoing studies enhanced quality of life improved intestinal absorption intestinal failure recommended for short bowel syndrome reduced parenteral nutrition needs |
| gptkbp:community_service |
available
|
| gptkbp:contraindication |
serious allergic reactions
hypersensitivity to teduglutide |
| gptkbp:date |
2012-08-30
|
| gptkbp:dosageForm |
injection
|
| gptkbp:drugInterdiction |
hormones
prescription only none significant subcutaneous absorption |
| gptkbp:hasPopulation |
adults
pediatric patients |
| gptkbp:healthcare |
injection technique
importance of adherence signs of allergic reaction |
| https://www.w3.org/2000/01/rdf-schema#label |
Gattex
|
| gptkbp:impact |
long-term
|
| gptkbp:insuranceAccepted |
varies by plan
|
| gptkbp:is_monitored_by |
nutritional status
weight gain fluid balance |
| gptkbp:manufacturer |
gptkb:NPS_Pharmaceuticals
|
| gptkbp:marketSegment |
available
|
| gptkbp:notableFeature |
gptkb:Gattex
|
| gptkbp:numberOfStudents |
approximately 13 hours
|
| gptkbp:nutritionalValue |
proteolytic cleavage
|
| gptkbp:offers |
varies by pharmacy
|
| gptkbp:packaging |
single-use vial
|
| gptkbp:patentType |
yes
|
| gptkbp:relatedPatent |
Crohn's disease
malabsorption syndromes intestinal resection |
| gptkbp:researchFocus |
cost-effectiveness
long-term effects quality of life assessments combination therapies pediatric applications |
| gptkbp:route |
subcutaneous injection
|
| gptkbp:sideEffect |
headache
nausea abdominal pain injection site reactions |
| gptkbp:storage |
refrigerated
|
| gptkbp:triggerType |
GLP-2 receptor agonist
|
| gptkbp:usedFor |
short bowel syndrome
|
| gptkbp:waterManagement |
urine
|